Literature DB >> 7846209

Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.

J L Azolosa1, M L Stitzer, M K Greenwald.   

Abstract

In acute dependence, signs and symptoms of opioid withdrawal are precipitated when an opioid antagonist (naloxone) is administered following acute (e.g. single dose) pretreatment with a mu agonist. This study examined the influence of amount of previous opioid exposure, both immediate and remote, on intensity of precipitated withdrawal effects in an acute dependence model. Two groups of subjects, opioid abusers (n = 20) and nonabusers (n = 20), received either one 15 mg/70 kg IM morphine pretreatment or two such pretreatments spaced 24 h apart. Naloxone challenge (30 mg/70 kg) followed 4.33 h after the second pretreatment. There were clear effects of morphine pretreatment condition (single versus repeated 15 mg) on the intensity of precipitated withdrawal responses elicited by naloxone. More intense effects were seen after the repeated pretreatment, suggesting that physical dependence escalates with repeated opioid exposures spaced at appropriate intervals. Subjects with an opioid abuse history reported greater liking of agonist drug effects than did nonabusers, whereas nonabusers reported more sedating effects. However, an opioid abuse history did not influence the intensity of precipitated withdrawal symptoms and signs. The latter finding suggests that a previous opioid exposure history does not dramatically modulate initial stages of physical dependence development during subsequent opioid exposure episodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846209     DOI: 10.1007/bf02245446

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Comparison of psychological effects of certain centrally acting drugs in man.

Authors:  C KORNETSKY; O HUMPHRIES; E V EVARTS
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-03

2.  Maternal and fetal distribution of H3-dihydromorphine in the tolerant and nontolerant rat.

Authors:  S Y Yeh; L A Woods
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

3.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

4.  Naloxone-precipitated jumping in mice pretreated with acute injections of opioids.

Authors:  J N Wiley; D A Downs
Journal:  Life Sci       Date:  1979-08-27       Impact factor: 5.037

5.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

6.  Opioid physical dependence development in humans: effect of time between agonist pretreatments.

Authors:  K C Kirby; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Methadone-naloxone mixtures for use in methadone maintenance programs. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence.

Authors:  J G Nutt; D R Jasinski
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

8.  Acute physical dependence induced by continuous intravenous infusion of morphine or meperidine in the rat.

Authors:  T Nakaki; M Saito; T Nakadate; Y Tokunaga; R Kato
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Comparison of intravenously administered methadone, morphine and heroin.

Authors:  D R Jasinski; K L Preston
Journal:  Drug Alcohol Depend       Date:  1986-07       Impact factor: 4.492

10.  Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts.

Authors:  L LASAGNA; J M VON FELSINGER; H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-03-19
View more
  22 in total

1.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

Review 2.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

3.  Context- and cue-conditioned potentiation of acute morphine dependence and withdrawal.

Authors:  Gery Schulteis; Jian Liu; Nurith Amitai; Sally Tzeng
Journal:  Pharmacol Biochem Behav       Date:  2005-08-24       Impact factor: 3.533

4.  Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.

Authors:  Nurith Amitai; Jian Liu; Gery Schulteis
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

5.  Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.

Authors:  S H Criner; J Liu; G Schulteis
Journal:  Neuroscience       Date:  2006-12-11       Impact factor: 3.590

6.  BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.

Authors:  Norikazu Kiguchi; Huiping Ding; Gerta Cami-Kobeci; Devki D Sukhtankar; Paul W Czoty; Heather B DeLoid; Fang-Chi Hsu; Lawrence Toll; Stephen M Husbands; Mei-Chuan Ko
Journal:  Br J Anaesth       Date:  2019-03-01       Impact factor: 9.166

7.  A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.

Authors:  Huiping Ding; Norikazu Kiguchi; Dennis Yasuda; Pankaj R Daga; Willma E Polgar; James J Lu; Paul W Czoty; Shiroh Kishioka; Nurulain T Zaveri; Mei-Chuan Ko
Journal:  Sci Transl Med       Date:  2018-08-29       Impact factor: 17.956

8.  Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.

Authors:  Gery Schulteis; Andrew C Morse; Jian Liu
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

9.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

10.  Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.